Russia becomes attractive as a source of IP for biotechs.
Katsnelson
Alla
A
D001709:Biotechnology / Q000331:legislation & jurisprudence* / Q000639:trends*; D016520:Entrepreneurship / Q000331:legislation & jurisprudence* / Q000639:trends; D033161:Government Regulation; D019983:Guideline Adherence / Q000331:legislation & jurisprudence*; D018973:Intellectual Property; D007373:Interinstitutional Relations; D007391:International Cooperation / Q000331:legislation & jurisprudence; D010067:Ownership / Q000331:legislation & jurisprudence* / Q000639:trends*; D017149:Private Sector / Q000331:legislation & jurisprudence / Q000639:trends; D017150:Public Sector / Q000331:legislation & jurisprudence / Q000639:trends; D012426:Russia